Literature DB >> 21220623

Retinal venular diameter as an early indicator of progression to proliferative diabetic retinopathy with and without high-risk characteristics in African Americans with type 1 diabetes mellitus.

Monique S Roy1, Ronald Klein, Malvin N Janal.   

Abstract

OBJECTIVE: To examine the relationship between retinal arteriolar and venular diameter and the 6-year progression of diabetic retinopathy (DR) in African Americans with type 1 insulin-dependent diabetes mellitus.
METHODS: Included were 468 African Americans with type 1 diabetes mellitus who participated in the New Jersey 725 and who had undergone a 6-year follow-up examination. Seven standard field retinal photographs were obtained at both examinations. Computer-assisted grading, from digitized images of field 1 of baseline retinal photographs, was accomplished to determine the average diameter of retinal arterioles (central retinal arteriolar equivalent [CRAE]) and venules (central retinal venular equivalent [CRVE]). Retinal vessel diameter was examined in relation to the 6-year incidence and/or progression of DR.
RESULTS: For right and left eyes, mean (SD) CRAE was 168.8 (16.0) μm and mean CRVE was 254.2 (25.2) μm. Both CRAE and CRVE were correlated between eyes (P < .001). Multivariate analysis with generalized estimating equations showed that larger CRVE in either the right or left eye was significantly associated with 6-year progression to either proliferative DR (PDR) or PDR with high-risk characteristics after adjusting for baseline clinical risk factors. Notably, a significant association between baseline CRVE and progression to PDR was present for eyes with no to moderate nonproliferative DR and also between baseline CRVE and progression to PDR with high-risk characteristics for eyes with no or nonproliferative DR.
CONCLUSION: Larger retinal venular diameter is an independent and early indicator of progression to either PDR or PDR with high-risk characteristics in African Americans with type 1 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21220623     DOI: 10.1001/archophthalmol.2010.340

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  25 in total

1.  Retinal vascular geometry and 6 year incidence and progression of diabetic retinopathy.

Authors:  Carol Yim-Lui Cheung; Charumathi Sabanayagam; Antony Kwan-Pui Law; Neelam Kumari; Daniel Shu-Wei Ting; Gavin Tan; Paul Mitchell; Ching Yu Cheng; Tien Yin Wong
Journal:  Diabetologia       Date:  2017-06-16       Impact factor: 10.122

2.  Fully automated geometric feature analysis in optical coherence tomography angiography for objective classification of diabetic retinopathy.

Authors:  David Le; Minhaj Alam; Bernadette A Miao; Jennifer I Lim; Xincheng Yao
Journal:  Biomed Opt Express       Date:  2019-04-22       Impact factor: 3.732

3.  Association between retinopathy and cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC] Study).

Authors:  Juan E Grunwald; Gui-Shuang Ying; Maureen Maguire; Maxwell Pistilli; Ebenezer Daniel; Judith Alexander; Revell Whittock-Martin; Candace Parker; Emile Mohler; Joan Chia-Mei Lo; Raymond Townsend; Crystal Ann Gadegbeku; James Phillip Lash; Jeffrey Craig Fink; Mahboob Rahman; Harold Feldman; John Walter Kusek; Dawei Xie; Martha Coleman; Martin Gerard Keane
Journal:  Am J Cardiol       Date:  2012-04-18       Impact factor: 2.778

4.  Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.

Authors:  Rupal Mehta; Gui Shuang Ying; Samuel Houston; Tamara Isakova; Lisa Nessel; Akinlolu Ojo; Alan Go; Jim Lash; John Kusek; Juan Grunwald; Myles Wolf
Journal:  Nephrol Dial Transplant       Date:  2015-04-24       Impact factor: 5.992

5.  Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study.

Authors:  Juan E Grunwald; Judith Alexander; Gui-Shuang Ying; Maureen Maguire; Ebenezer Daniel; Revell Whittock-Martin; Candace Parker; Kathleen McWilliams; Joan C Lo; Alan Go; Raymond Townsend; Crystal A Gadegbeku; James P Lash; Jeffrey C Fink; Mahboob Rahman; Harold Feldman; John W Kusek; Dawei Xie; Bernard G Jaar
Journal:  Arch Ophthalmol       Date:  2012-09

6.  Retinopathy and the risk of cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort study).

Authors:  Juan E Grunwald; Maxwell Pistilli; Gui-Shuang Ying; Maureen Maguire; Ebenezer Daniel; Revell Whittock-Martin; Candace Parker-Ostroff; Emile Mohler; Joan C Lo; Raymond R Townsend; Crystal Ann Gadegbeku; James Phillip Lash; Jeffrey Craig Fink; Mahboob Rahman; Harold Feldman; John W Kusek; Dawei Xie
Journal:  Am J Cardiol       Date:  2015-08-31       Impact factor: 2.778

7.  Changes in retinal vessel diameter and incidence and progression of diabetic retinopathy.

Authors:  Ronald Klein; Chelsea E Myers; Kristine E Lee; Ronald Gangnon; Barbara E K Klein
Journal:  Arch Ophthalmol       Date:  2012-06

8.  The Relationship of Retinal Vessel Geometric Characteristics to the Incidence and Progression of Diabetic Retinopathy.

Authors:  Ronald Klein; Kristine E Lee; Lorraine Danforth; Michael Y Tsai; Ronald E Gangnon; Stacy E Meuer; Tien Y Wong; Carol Y Cheung; Barbara E K Klein
Journal:  Ophthalmology       Date:  2018-05-18       Impact factor: 12.079

Review 9.  Biomarkers in Diabetic Retinopathy.

Authors:  Alicia J Jenkins; Mugdha V Joglekar; Anandwardhan A Hardikar; Anthony C Keech; David N O'Neal; Andrzej S Januszewski
Journal:  Rev Diabet Stud       Date:  2015-08-10

10.  Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes.

Authors:  Monique S Roy; Malvin N Janal; Juan Crosby; Robert Donnelly
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-13       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.